Insider · CIK 0002023998
Jennifer Sy
Files at AEON (AEON Biopharma, Inc.). First filing -, latest -.
In brief
Jennifer Sy files SEC Form 4 as officer at AEON (AEON Biopharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jennifer Sy has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | AEON AEON Biopharma, Inc. | AGrant or award Class A Common Stock | +575,000 | $0.00 | $0 | 575,251 | Mar 5, 2026 |
| Mar 4, 2026 | AEON AEON Biopharma, Inc. | AGrant or award Class A Common Stock | +925,925 | $0.00 | $0 | 1,501,176 | Mar 5, 2026 |
| May 21, 2025 | AEON AEON Biopharma, Inc. | AGrant or award Restricted Stock Unitsderivative | +925,925 | $0.00 | $0 | 925,925 | May 23, 2025 |
Questions about Jennifer Sy
Answered from the filings on this page, as of the latest one.
Is Jennifer Sy buying or selling?
Jennifer Sy has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jennifer Sy's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jennifer Sy has 0.
Where does Jennifer Sy file Form 4?
Jennifer Sy has filed Form 4 at AEON (AEON Biopharma, Inc.) as PRINCIPAL ACCOUNTING OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.